Sign in Subscribe
Cancer research

T Cell Exhaustion-Related Gene CD79B Predicts Prognosis in Lung Adenocarcinoma

Strategic Insights

— 1 min read

Researchers at Central South University in Hunan, China, have investigated the role of T cell exhaustion (TEX) in lung adenocarcinoma (LUAD). Lung adenocarcinoma is a common malignancy in the lung, and T cell exhaustion is an important immune escape mechanism that may be targeted to improve tumor immunotherapy. The study, published in Oncology Reports, analyzed data from 516 patients with LUAD and identified a TEX-related gene signature that predicts prognosis.

Key Takeaways:

  • The study found that patients with LUAD in the TEX-C2 cluster had worse prognosis, with shorter overall and progression-free survival, compared to those in the TEX-C1 cluster.
  • The TEX-C2 cluster had a poor immune checkpoint blockade (ICB) response and a shorter survival after ICB treatment.
  • A prognostic TEX-related gene signature was constructed for patients with LUAD, which included the B cell antigen receptor complex-associated protein b chain (CD79B) as an independent prognostic indicator.
  • CD79B overexpression was associated with more infiltration of CD8 T cells, M1 macrophages, and less infiltration of M0 and M2 macrophages.
  • Upregulation of CD79B could inhibit the proliferation, migration, and invasion capabilities and promote the apoptosis of LUAD cells, and induce M1-like tumor-associated macrophage (TAM) polarization.

Statistics:

  • 516 patients with LUAD were analyzed in the study.
  • The TEX-C2 cluster had a worse prognosis, with a shorter overall survival (OS) of 22.5 months compared to 31.8 months in the TEX-C1 cluster.
  • The TEX-C2 cluster also had a poorer progression-free survival (PFS) of 15.6 months compared to 22.1 months in the TEX-C1 cluster.
  • CD79B overexpression was associated with a higher level of immune checkpoint genes, with an increase of 2.5-fold in CD274 (PD-L1) expression.

Sources:

  • Oncology Reports, 2025; 54(5)
  • Central South University, Changsha, Hunan 410078, People's Republic of China
  • Cancer Research Institute, School of Basic Medicine Science, Central South University
  • Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece

Read more